izpis_h1_title_alt

Screening of big pharma’s library against various in-house biological targets
ID Knez, Damijan (Author), ID Gobec, Stanislav (Author), ID Hrast, Martina (Author)

URLURL - Source URL, Visit https://www.mdpi.com/1420-3049/27/14/4484 This link opens in a new window
.pdfPDF - Presentation file, Download (8,55 MB)
MD5: 8C682560C0DAFEFC65F01DC190D65854

Abstract
Open innovation initiatives provide opportunities for collaboration and sharing of knowledge and experience between industry, academia, and government institutions. Through open innovation, Merck is offering a Mini Library of 80 carefully selected compounds from previous research and development projects to a broader scientific community for testing in academic drug discovery projects. These compounds are predominantly drug-like and cover a broad range of molecular targets. They could potentially interact with other enzymes, receptors, transporters, and ion channels of interest. The Mini Library was tested on seven in-house enzymes (bacterial MurA, MurC ligase, and DdlB enzyme, human MAO-A/B, human BChE, and murine AChE), and several hits were identified. A follow-up series of structural analogues provided by Merck gave a more detailed insight into the accessibility and the quality of the hit compounds. For example, sartan derivatives were moderate inhibitors of MurC, whereas bisarylureas were potent, selective, nanomolar inhibitors of hMAO-B. Importantly, 3-n-butyl-substituted indoles were identified as low nanomolar selective inhibitors of hBChE. All in all, the hit derivatives provide new starting points for the further exploration of the chemical space of high-quality enzyme inhibitors.

Language:English
Keywords:Merck Mini Library, screening, MurA, MurC, human MAO-A/B, human BChE, murine AchE
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Publication date:13.08.2022
Year:2022
Number of pages:12 str.
Numbering:Vol. 27, iss. 14, art. 4484
PID:20.500.12556/RUL-138679 This link opens in a new window
UDC:615.4:54
ISSN on article:1420-3049
DOI:10.3390/molecules27144484 This link opens in a new window
COBISS.SI-ID:117586947 This link opens in a new window
Publication date in RUL:09.08.2022
Views:366
Downloads:80
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Molecules
Shortened title:Molecules
Publisher:MDPI
ISSN:1420-3049
COBISS.SI-ID:18462981 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:09.08.2022

Secondary language

Language:Slovenian
Keywords:Merckova mini knjižnica, pregledovanje, humani MAO-A/B, humani BChE, mišji AchE

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARRS - Slovenian Research Agency
Project number:Z1-1859
Name:Kovalentni zaviralci: zaviranje monoamin oksidaze preko nekatalitskih aminokislinskih ostankov

Funder:ARRS - Slovenian Research Agency
Project number:J1-2484
Name:Razvoj protibakteriskih učinkovin z delovanjem na validirane tarče v biosintezi peptidoglikana

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back